Literature DB >> 10190331

Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations.

S Usami1, S Abe, M D Weston, H Shinkawa, G Van Camp, W J Kimberling.   

Abstract

Enlarged vestibular aqueduct (EVA), known as the most common form of inner ear abnormality, has recently been of particular genetic interest because this anomaly is inherited in a recessive manner. The locus for non-syndromic sensorineural hearing loss with EVA has been mapped to the same chromosomal region, 7q31, as the Pendred syndrome locus. In the present study, seven mutations in the PDS gene (PDS), the gene responsible for Pendred syndrome, have been found in families of non-syndromic sensorineural hearing loss with EVA. One family is homozygous, three families are compound heterozygotes, and two families are heterozygous but with no other mutation detected. The present results provide evidence that mutations in PDS cause both syndromic and non-syndromic hearing loss.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10190331     DOI: 10.1007/s004390050933

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  72 in total

1.  Recurrent meningitis and cerebrospinal fluid leak-two sides of the same vestibulocochlear defect: report of three cases.

Authors:  M Ben-Shoshan; A DeRowe; G Grisaru-Soen; L Ben-Sira; E Miller
Journal:  Eur J Pediatr       Date:  2006-08-31       Impact factor: 3.183

Review 2.  Pharmacogenomics and systems biology of membrane transporters.

Authors:  Qing Yan
Journal:  Mol Biotechnol       Date:  2005-01       Impact factor: 2.695

3.  A new locus for nonsyndromic deafness DFNB51 maps to chromosome 11p13-p12.

Authors:  Rehan Sadiq Shaikh; Khushnooda Ramzan; Sabiha Nazli; Sameera Sattar; Shaheen N Khan; Saima Riazuddin; Zubair M Ahmed; Thomas B Friedman; Sheikh Riazuddin
Journal:  Am J Med Genet A       Date:  2005-11-01       Impact factor: 2.802

4.  Large Na(+) influx and high Na(+), K (+)-ATPase activity in mitochondria-rich epithelial cells of the inner ear endolymphatic sac.

Authors:  Takenori Miyashita; Hitoshi Tatsumi; Kimihide Hayakawa; Nozomu Mori; Masahiro Sokabe
Journal:  Pflugers Arch       Date:  2006-12-05       Impact factor: 3.657

5.  Transcriptional control of SLC26A4 is involved in Pendred syndrome and nonsyndromic enlargement of vestibular aqueduct (DFNB4).

Authors:  Tao Yang; Hilmar Vidarsson; Sandra Rodrigo-Blomqvist; Sally S Rosengren; Sven Enerback; Richard J H Smith
Journal:  Am J Hum Genet       Date:  2007-04-23       Impact factor: 11.025

6.  AUNX1, a novel locus responsible for X linked recessive auditory and peripheral neuropathy, maps to Xq23-27.3.

Authors:  Q J Wang; Q Z Li; S Q Rao; K Lee; X S Huang; W Y Yang; S Q Zhai; W W Guo; Y F Guo; N Yu; Y L Zhao; H Yuan; J Guan; S M Leal; D Y Han; Y Shen
Journal:  J Med Genet       Date:  2006-07       Impact factor: 6.318

Review 7.  DENTAL ENAMEL FORMATION AND IMPLICATIONS FOR ORAL HEALTH AND DISEASE.

Authors:  Rodrigo S Lacruz; Stefan Habelitz; J Timothy Wright; Michael L Paine
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

8.  Long-term follow-up in patients with Pendred syndrome: vestibular, auditory and other phenotypes.

Authors:  Makoto Sugiura; Eisuke Sato; Tsutomu Nakashima; Junko Sugiura; Atsushi Furuhashi; Takahiko Yoshino; Atsuo Nakayama; Naoyoshi Mori; Hideki Murakami; Shinji Naganawa
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-04       Impact factor: 2.503

9.  Evaluation of the thyroid in patients with hearing loss and enlarged vestibular aqueducts.

Authors:  Anne C Madeo; Ani Manichaikul; James C Reynolds; Nicholas J Sarlis; Shannon P Pryor; Thomas H Shawker; Andrew J Griffith
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-07

10.  Construction of a DNA chip for screening of genetic hearing loss.

Authors:  Soo-Young Choi; Young-Eun Kim; Dong-Bin Ahn; Tae-Hoon Kim; Jae-Hyuk Choi; Hye-Ryung Lee; Sang-Joon Hwang; Un-Kyung Kim; Sang-Heun Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-03-26       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.